Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects

Advances in Anatomic Pathology

Volumn 11, Issue 3, 2004, Pages 117-142

  Clement, Philip B ^a   Young, Robert H ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carcinomas; Clear cell; Endometrium; Metastatic; Mucinous; Secondary; Serous; Small cell; Squamous cell; Transitional cell; Undifferentiated

Indexed keywords

CARCINOMA; FEMALE; HISTORY; HUMAN; PATHOLOGY; REVIEW; UTERUS CANCER;

CARCINOMA; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; PATHOLOGY; UTERINE NEOPLASMS;

EID: 6944253953     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200405000-00001     Document Type: Review

References (187)

1. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2002;9:145-184.
2. Cullen TS. Cancer of the uterus. Its pathology, symptomatology, diagnosis, and treatment. New York: Appleton; 1900.
3. Young RH. Dusting off old books: Comments on classic gynecologic pathology books of yesteryear. Int J Gynecol Pathol. 2000;19:67-84. (Pubitemid 30010643)
4. Young RH. History of gynecologic pathology. I. Dr. Thomas S. Cullen. Int J Gynecol Pathol. 1996;15:181-186.
5. Kay S. Clear-cell carcinoma of the endometrium. Cancer. 1957;10:124-130.
6. Silverberg SG, DeGiorgi LS. Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings. Cancer. 1973;31:1127-1140.
7. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer. 1976;37:872-882.
8. Factor SM. Papillary adenocarcinoma of the endometrium with psammoma bodies. Arch Pathol Lab Med. 1974;98:201-205.
9. Hendrickson MR, Kempson RL. Surgical Pathology of the Uterine Corpus. Vol 12. Major Problems in Pathology. Philadelphia: WB Saunders; 1980.
10. Lauchlan SC. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med. 1981;105:615-618. (Pubitemid 11020875)
11. Hendrickson MR, Ross J, Eifel P, et al. Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93-108. (Pubitemid 12108965)
12. Walker AN, Mills SE. Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases. Diagn Gynecol Obstet. 1982;4:261-267. (Pubitemid 13113482)
13. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium II. Papillary adenocarcinoma: A clinical pathological study of 46 cases. Am J Clin Pathol. 1982;77:534-540. (Pubitemid 12112396)
14. Hendrickson M, Ross J, Eifel PJ, et al. Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinoma limited to the uterine corpus. Gynecol Oncol. 1982;13:373-392.
15. Eifel PJ, Ross J, Hendrickson M, et al. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: Treatment comparisons. Cancer. 1983;52:1026-1031. (Pubitemid 13050768)
16. Gallion HH, Van Nagell JR Jr, Powell DF, et al. Stage I serous papillary carcinoma of the endometrium. Cancer. 1989;63:2223-2228.
17. O'Hanlan KA, Levine PA, Harbatkin D, et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol. 1990;37:112-119. (Pubitemid 20147981)
18. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumors. World Health Organization. Second Edition. Springer-Verlag: New York; 1994.
19. Mathews RP, Hutchinson-Colas J, Maiman M, et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol. 1997;65:206-212. (Pubitemid 27216929)
20. Parkash V, Carcangiu ML. Uterine papillary serous carcinoma after radiation therapy for carcinoma of the cervix. Cancer. 1992;69:496-501.
21. Silva EG, Tornos CS, Follen-Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: The effects of tamoxifen. Int J Gynecol Pathol. 1994;13:248-258. (Pubitemid 24190983)
22. McCluggage WG, Sumathi VP, McManus DT. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising endometrial polyps: Report of 5 cases including 2 associated with tamoxifen therapy. Hum Pathol. 2003;34:939-943. (Pubitemid 37169625)
23. Goshen R, Chu W, Elit L, et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol. 2000;79:477-481.
24. Lavie O, Hornreich G, Ben Arie A, et al. BRCA1 germline mutations in women with uterine serous papillary carcinoma. Obstet Gynecol. 2000;96:28-32. (Pubitemid 30336275)
25. Geisler JP, Sorosky JI, Duong H-L, et al. Papillary serous carcinoma of the uterus: Increased risk of subsequent or concurrent development of breast carcinoma. Gynecol Oncol. 2001;83:501-503. (Pubitemid 33139710)
26. Elit L, Pal T, Goshen R, et al. Familial and hormonal risk factors for papillary serous carcinoma. Eur J Gynaecol Oncol. 2002;23:187-190. (Pubitemid 34625322)
27. Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma: A single institution review of 129 cases. Gynecol Oncol. 2003;91:463-469. (Pubitemid 38388137)
28. Hornreich G, Beller U, Lavie O, et al. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature. Gynecol Oncol. 1999;75:300-304. (Pubitemid 29523039)
29. Kuebler DL, Nikrui N, Bell DA. Cytologic features of endometrial papillary serous carcinoma. Acta Cytol. 1989;33:120-126. (Pubitemid 19063077)
30. Williams KE, Waters ED, Woolas RP, et al. Mixed serous-endometrioid carcinoma of the uterus: Pathologic and cytopathologic analysis of high-risk endometrial carcinoma. Int J Gynecol Cancer. 1994;4:7-18. (Pubitemid 24012217)
31. Tseng PC, Sprance HE, Carcangiu ML, et al. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma. Obstet Gynecol. 1989;74:384-387. (Pubitemid 19213928)
32. Price FV, Chambers S, Carcangiu ML, et al. CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer. 1998;82:1720-1725.
33. Fukuma K, Miyamura S, Thoya T, et al. Uterine papillary serous carcinoma with high levels of serum carcinoembryonic antigen. Response to chemotherapy. Cancer. 1987;59:403-405. (Pubitemid 17002414)
34. Sachmechi I, Kalra J, Molho L, et al. Paraneoplastic hypercalcemia associated with uterine papillary serous carcinoma. Gynecol Oncol. 1995;58:378-382.
35. Ng JS, Han AC, Edelson MI, et al. Uterine papillary serous carcinoma presenting as distant lymph node metastasis. Gynecol Oncol. 2001;80:417-420. (Pubitemid 32207548)
36. Jordan LB, Abdul-Kader M, Al-Nafussi A. Uterine serous papillary carcinoma: Histopathologic changes within the female genital tract. Int J Gynecol Cancer. 2001;11:283-289. (Pubitemid 32751396)
37. Cirisano FD, Robboy SJ, Dodge RK, et al. Epidemiologic and surgicopathologic findings of papillary srous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol. 1999;74:385-394. (Pubitemid 29439878)
38. Geisler JP, Geisler HE, Melton ME, et al. What staging surgery should be performed on patients with uterine papillary serous carcinoma? Gynecol Oncol. 1999;74:465-467. (Pubitemid 29439891)
39. Chan JK, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staging in non-invasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003;90:181-185. (Pubitemid 37338095)
40. Sherman ME, Bitterman P, Rosenshein NB, et al. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol. 1992;16:600-610.
41. Hendrickson MR, Longacre TA, Kempson RL. Uterine papillary serous carcinoma revisited. Gynecol Oncol. 1994;54:261-263. (Pubitemid 24301897)
42. Venkatraman K, Elliott H, Steele EK, et al. Serous carcinoma arising in an adenofibroma of the endometrium. Int J Gynecol Pathol. 2003;22:194-197. (Pubitemid 36348796)
43. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol. 1990;3:120-128.
44. Lee KR, Belinson JL. Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma. Am J Surg Pathol. 1991;15:965-973.
45. Wheeler DT, Bell KA, Kurman RJ, et al. Minimal uterine serous carcinoma. Am J Surg Pathol. 2000;24:797-806.
46. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol. 1992;47:298-305. (Pubitemid 23011408)
47. Ambros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995;26:1260-1267.
48. Spiegel GW. Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol. 1995;19:417-432.
49. Zheng W, Khurana R, Farahmand S, et al. p53 immunostaining as a significant adjunct test for uterine surface carcinoma. Precursor of uterine papillary serous carcinoma. Am J Surg Pathol. 1998;22:1463-1473. (Pubitemid 28550641)
50. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol. 2000;24:726-732. (Pubitemid 30253511)
51. Baergen RN, Warren CD, Isacson C, et al. Early uterine serous carcinoma: Clonal origin of extrauterine disease. Int J Gynecol Pathol. 2001;20:214-219. (Pubitemid 32578105)
52. Sasano H, Comerford J, Wilkinson DS, et al. Serous papillary adenocarcinoma of the endometrium. Analysis of proto-oncogen amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry. Cancer. 1990;65:1545-1551. (Pubitemid 20106113)
53. Prat J, Oliva E, Lerma E, et al. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content. Cancer. 1994;74:1778-1783. (Pubitemid 24301833)
54. Santin AD. Her2/neu "overexpression" has the Achilles' heel of uterine serous papillary carcinoma been exposed? Gynecol Oncol. 2003;88:263-265. (Pubitemid 36331976)
55. Bancher-Todesca D, Gitsch G, Williams KE, et al. p53 protein overexpression: A strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol. 1998;71:59-63. (Pubitemid 28492394)
56. King SA, Adas AA, Li-Volsi VA, et al. Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma. Cancer. 1995;75:2700-2705.
57. Moll UM, Chalas E, Auguste M, et al. Uterine papillary serous carcinoma evolves via a p53-driven pathway. Hum Pathol. 1996;27:1295-1300. (Pubitemid 26415322)
58. Tashiro H, Isacson C, Levine R, et al. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997;150:177-185. (Pubitemid 27027108)
59. Kovalev S, Marchenko ND, Gugliotta BG, et al. Loss of p53 function in uterine papillary serous carcinoma. Hum Pathol. 1998;29:613-619. (Pubitemid 28272717)
60. Soslow RA, Shen PU, Chung MH, et al. Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma. Int J Gynecol Pathol. 1998;17:129-134. (Pubitemid 28151011)
61. Kounelis S, Kapranos N, Kouri E, et al. Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature. Mod Pathol. 2000;13:379-388.
62. Suh K-S, Sim H-S, Na S-Y, et al. PTEN and p53 mutations in endometrial carcinomas. Abstract. Mod Pathol. 2004;17:215A.
63. Lax SF, Kendall B, Tashiro H, et al. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma. Cancer. 2000;88:814-824. (Pubitemid 30091101)
64. Schmitz MJ, Hendricks DT, Farley J, et al. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma. Gynecol Oncol. 2000;77:439-445. (Pubitemid 30368564)
65. Zheng W, Cao P, Zheng M, et al. p53 overexpression and bcl-2 persistence in endometrial carcinoma: Comparison of papillary serous and endometrioid carcinoma. Gynecol Oncol. 1996;61:167-174. (Pubitemid 26145719)
66. Peng HQ, Ionescu M, Jeganathan R, et al. Expression of E-cadherin and beta-catenin in endometrioid and papillary serous carcinoma of the endometrium. Abstract. Mod Pathol. 2004;17:210A.
67. Tashiro H, Lax SF, Gaudin PB, et al. Microsatellite instability is uncommon in uterine serous carcinoma. Am J Pathol. 1997;150:75-79. (Pubitemid 27027098)
68. Lee KR, Belinson JL. Papillary serous adenocarcinoma of the endometrium: A clinicopathologic study of 19 cases. Gynecol Oncol. 1992;46:51-54.
69. Kato DT, Ferry JA, Goodman A, et al. Uterine papillary serous carcinoma (UPSC): A clinicopathologic study of 30 cases. Gynecol Oncol. 1995;59:384-389.
70. Grice J, El M, Greer B, et al. Uterine papillary serous carcinoma: Evaluation of long-term survival in surgically staged patients. Gynecol Oncol. 1998;69:69-73. (Pubitemid 28201674)
71. Lim P, Al Kushi A, Gilks B, et al. Early stage uterine papillary serous carcinoma of the endometrium. Cancer. 2001;91:752-757.
72. Nguyen NP, Sallah S, Karlsson U, et al. Prognosis for papillary serous carcinoma of the endometrium after surgical staging. Int J Gynecol Cancer. 2001;11:305-311. (Pubitemid 32751400)
73. Bristow RE, Asrari F, Trimble EL, et al. Extended surgical staging for uterine papillary serous carcinoma: Survival outcome of locoregional (stage I-III) disease. Gynecol Oncol. 2001;81:279-286. (Pubitemid 32424175)
74. Carcangiu ML, Tan LK, Chambers JT. Stage IA uterine serous carcinoma. A study of 13 cases. Am J Surg Pathol. 1997;21:1507-1514. (Pubitemid 27528263)
75. Gehrig PA, Groben PA, Fowler WC Jr, et al. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol. 2001;97:153-157. (Pubitemid 32057174)
76. Goff BA, Kato D, Schmidt RA, et al. Uterine papillary serous carcinoma: Patterns of metastatic spread. Gynecol Oncol. 1994;554:264-268. (Pubitemid 24301898)
77. Murray SK, Young RH, Scully RE. Uterine endometrioid carcinoma with small nonvillous papillae: An analyis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma. Int J Surg Pathol. 2000;8:279-289. (Pubitemid 32120690)
78. Parkash V, Carcangiu ML. Endometrioid endometrial adenocarcinoma with psammoma bodies. Am J Surg Pathol. 1997;21:399-406. (Pubitemid 27184772)
79. Abdul-Karim FW, Bennert KW, MacFee M. Accidental detection of nonmetastatic ovarian adenocarcinoma in tissue samples recovered during dilatation and curettage. Int J Gynecol Pathol. 1993;12:355-359. (Pubitemid 23284815)
80. Ramalingam P, Middleton LP, Tamboli P, et al. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: Diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann Diagn Pathol. 2003;7:112-119. (Pubitemid 36523046)
81. Schust DJ, Moore DH, Baird DB, et al. Primary adenocarcinoma of the gallbladder presenting as primary gynecologic malignancy. A report of two cases. Obstet Gynecol. 1994;83:831-834. (Pubitemid 24154848)
82. Kraus FT. Irradiation changes in the uterus. In: Norris HJ, Hertig AT (eds): The Uterus. Internal Academy of Pathology Monographs in Pathology. Williams & Wilkins; Baltimore, 1973:457-488.
83. Silverberg SG, DeGiorgi LS. Histopathologic analysis of preoperative radiation therapy in endometrial carcinoma. Am J Obstet Gynecol. 1974;119:698-704.
84. Zheng W, Liang SX, Yu HH, et al. Endometrial glandular dysplasia - A newly identified non-cancerous precursor lesion highly associated with uterine papillary serous carcinoma. Abstract. Mod Pathol. 2004;17:219A.
85. Lehman MB, Hart WR. Simple and complex hyperplastic papillary proliferations of the endometrium. A clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol. 2001;25:1347-1354. (Pubitemid 33022049)
86. Karim R, Russell P. An unusual polypoid lesion. Pathology. 2003;35:522-525.
87. Silverberg SG, De Giorgi LS. Clear cell carcinoma of the endometrium. Cancer. 1973;31:1127-1140.
88. Photopoulos GJ, Carney CN, Edelman DA, et al. Clear cell carcinoma of the endometrium. Cancer. 1979;43:1448-1456. (Pubitemid 9180313)
89. Shankar Giri PG, Schneider V, Belgrad R. Clear cell carcinoma of the endometrium: An uncommon entity with a favourable prognosis. Int J Rad Oncol Biol Phys. 1981;7:1383-1387. (Pubitemid 12241703)
90. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer. 1982;49:1511-1523. (Pubitemid 12146934)
91. Webb GA, Lagios MD. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol. 1987;156:1486-1491. (Pubitemid 17087177)
92. Abeler VM, Kjorstad KE. Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 cases. Gynecol Oncol. 1991;40:207-217.
93. Crum CP, Fechner RE. Clear cell adenocarcinoma of the endometrium. A clinicopathologic study of 11 cases. Am J Diagn Gynecol Obstet. 1979;1:261-267. (Pubitemid 11190385)
94. Hutchesson ACJ, Dunne F, Bundred NJ, et al. Parathyroid hormone-related protein as a tumour parker in humoral hypercalcemia associated with occult malignancy. Postgrad Med J. 1993;69:640-642. (Pubitemid 23241579)
95. Dallenbach-Hellweg G, Hahn U. Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens. Int J Gynecol Pathol. 1995;14:7-15.
96. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium An analysis of 21 cases. Cancer. 1976;37:872-882.
97. Kanbour-Shakir A, Tobon H. Primary clear cell carcinoma of the endometrium: A clinicopathologic study of 20 cases. Int J Gynecol Pathol. 1991;10:67-78.
98. Malpica A, Tornos C, Burke TW, et al. Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 1995;19:769-774.
99. Peters WM, Wells M, Bryce FC. Mullerian clear cell carcinofibroma of the uterine corpus. Histopathology. 1984;8:1069-1078. (Pubitemid 15159737)
100. Lax SF, Pizer ES, Ronnett BM, et al. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol. 1998;29:551-558. (Pubitemid 28272707)
101. Abeler VM, Vergote IB, Kjorstad KE, et al. Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern. Cancer. 1996;78:1740-1747. (Pubitemid 26330902)
102. Carcangiu ML, Chambers JT. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: Comparison of clinicopathologic features and survival. Int J Gynecol Pathol. 1995;14:30-38.
103. Murphy KT, Rotmensch J, Yamada SD, et al. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: Implications for adjuvant radiation therapy. Int J Rad Oncol Biol Phys. 2003;55:1272-1276. (Pubitemid 36338293)
104. Zaino RJ. Pathologic indicators of prognosis in endometrial adenocarcinoma. Selected aspects emphasizing the GOG experience. Pathol Annu. 1995;30:1-28.
105. Silva EG, Deavers MT, Bodurka DC, et al. Uterine epithelioid leiomyosarcoma with clear cells. Reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol. 2004;28:244-249. (Pubitemid 38124734)
106. Vang R, Kempson RL. Perivascular epithelioid cell tumor ('PEComa') of the uterus. A subset of HMB-45 positive epithelioid mesenchymal neoplasm with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol. 2002;26:1-13. (Pubitemid 34019987)
107. Hendrickson MR, Kempson RL. Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol. 1980;4:525-542. (Pubitemid 11104410)
108. Nakashima N, Nagasaka T, Murakami S, et al. Endometrial atypical hyperplasia with clear cell change spreading throughout the endometrium. Ann Diagn Pathol. 2003;7:381-386. (Pubitemid 38017995)
109. Czernobilsky B, Katz Z, Lancet M, et al. Endocervical-type epithelium in endometrial carcinoma. A report of 10 cases with emphasis on histochemical methods for differential diagnosis. Am J Surg Pathol. 1980;4:481-489. (Pubitemid 10018814)
110. Ross JC, Eifel PJ, Cox RS, et al. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol. 1983;7:715-729. (Pubitemid 14222460)
111. Melham MF, Tobon H. Mucinous adenocarcinoma of the endometrium: A clinico-pathological review of 18 cases. Int J Gynecol Pathol. 1987;6:347-355.
112. Nucci MR, Prasad CJ, Crum CP, et al. Mucinous endometrial epithelial proliferations: A morphologic spectrum of changes with diverse clinical significance. Mod Pathol. 1999;12:1137-1142. (Pubitemid 30033547)
113. Vang R, Tavassoli FA. Proliferative mucinous lesions of the endometrium: Analysis of existing criteria for diagnosing carcinoma in biopsies and curettings. Int J Surg Pathol. 2003;11:261-270. (Pubitemid 37433285)
114. Leslie KO, Silverberg SG. Microglandular hyperplasia of the cervix: Unusual clinical and pathological presentations and their differential diagnosis. Prog Surg Pathol. 1984;5:95-114.
115. Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia: A report of six cases. Am J Surg Pathol. 1992;16:1092-1097.
116. Zaloudek C, Hayashi GM, Ryan IP, et al. Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol. 1997;16:52-59.
117. Fukunaga M. Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix. Pathol Int. 2000;50:541-545. (Pubitemid 30609862)
118. Zheng W, Yang GCH, Godwin TA, et al. Mucinous adenocarcinoma of the endometrium with intestinal differentiation: A case report. Hum Pathol. 1995;26:1385-1388. (Pubitemid 26001604)
119. Mooney EE, Robboy SJ, Hammond CB, et al. Signet-ring carcinoma of the endometrium: A primary tumor masquerading as a metastasis. Int J Gynecol Pathol. 1997;16:169-172. (Pubitemid 27231299)
120. Kamoi S, AlJuboury MI, Akin M, et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: Another viewpoint. Int J Gynecol Pathol. 2002;21:217-223. (Pubitemid 34680337)
121. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002;41:185-207. (Pubitemid 35013941)
122. McCluggage WG, Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol. 2003;22:231-235.
123. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas. Immunohistochemical p16 expression correlated with human papillomvirus (HPV) DVA detection. Am J Surg Pathol. 2004;28:160-167. (Pubitemid 38124723)
124. Kumar NB, Hart WR. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer. 1982;50:2163-2169. (Pubitemid 13203625)
125. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49:2547-2559. (Pubitemid 12125049)
126. Goodman A, Zukerberg LR, Rice LW, et al. Squamous cell carcinoma of the endometrium: A report of eight cases and a review of the literature. Gynecol Oncol. 1996;61:54-60. (Pubitemid 26108530)
127. Seltzer VL, Klein M, Beckman M. The occurrence of squamous metaplasia as a precursor of squamous cell carcinoma of the endometrium. Obstet Gynecol. 1977;49(suppl.):34S-37S.
128. Kataoka A, Nishida T, Sugiyama T, et al. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol. 1997;65:180-184. (Pubitemid 27171572)
129. Fluhmann CF. Squamous epithelium in the endometrium in benign and malignant conditions. Surg Gynecol Obstet. 1928;46:309-316.
130. Dalrymple JC, Russell P. Squamous endometrial neoplasia - are Fluhmann's postulates still relevant? Int J Gynecol Cancer. 1995;5:421-425.
131. Ryder DE. Verrucous carcinoma of the endometrium - a unique neoplasm with a long survival. Obstet Gynecol. 1982;59:78S-80S. (Pubitemid 12107297)
132. Hussain SF. Verrucous carcinoma of the endometrium. APMIS. 1988;96:1075-1078.
133. Shidara Y, Karube A, Watanabe M, et al. A case report: Verrucous carcinoma of the endometrium - the difficulty of diagnosis, and a review of the literature. J Obstet Gynaecol Res. 2000;26:189-192. (Pubitemid 30410217)
134. Yamashina M, Kobara TY. Primary squamous cell carcinoma with its spindle cell variant in the endometrium. A case report and review of literature. Cancer. 1986;57:340-345. (Pubitemid 16212040)
135. Pins MR, Young RH, Crum CP, et al. Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: Report of a case with human papilloma virus analysis. Int J Gynecol Pathol. 1997;16:272-278. (Pubitemid 27282302)
136. Baggish MS, Woodruff JD. The occurrence of squamous epithelium in the endometrium. Obstet Gynecol Surv. 1967;22:69-115.
137. Brown D Jr, Spjut HJ. Extensive squamous metaplasia of the endometrium (ichthyosis uteri). Southern Med J. 1982;75:592-595.
138. Sherwood JB, Carlson JA Jr, Gold MA, et al. Squamous metaplasia of the endometrium associated with HPV 6 and 11. Gynecol Oncol. 1997;66:141-145. (Pubitemid 27329322)
139. Chen KTK. Extraovarian transitional cell carcinoma of female genital tract. Letter. Am J Clin Pathol. 1990;94:670-671. (Pubitemid 20369742)
140. Spiegel GW, Austin RM, Gelven PL. Transitional cell carcinoma of the endometrium. Gynecol Oncol. 1996;60:325-330. (Pubitemid 26058782)
141. Lininger RA, Ashfag R, Albores-Saavedra J, et al. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation. Cancer. 1997;79:1933-1943. (Pubitemid 27200377)
142. Fukunaga M, Ushigone S. Transitional cell carcinoma of the endometrium. Letter. Histpathology. 1998;32:284-286.
143. Labonté S, Tétu B, Boucher D, et al. Transitional cell carcinoma of the endometrium associated with a benign Brenner tumor: A case report. Hum Pathol. 2001;32:230-232. (Pubitemid 32193723)
144. Lininger RA, Wistuba I, Gazdar A, et al. Human papillomavirus type 16 is detected in transitional cell carcinomas and squamotransitional cell carcinomas of the cervix and endometrium. Cancer. 1998;83:521-527. (Pubitemid 28354508)
145. Vargas MP, Merino MJ. Lymphoepitheliomalike carcinoma: An unusual variant of endometrial cancer. A report of two cases. Int J Gynecol Pathol. 1998;17:272-276. (Pubitemid 28299743)
146. Hoshida Y, Nagakawa T, Mano S, et al. Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production. Int J Gynecol Pathol. 1996;15:266-269. (Pubitemid 26227286)
147. Yamamoto R, Ishikura H, Azuma M, et al. Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus. J Clin Pathol. 1996;49:420-422. (Pubitemid 26000331)
148. Toyoda H, Hirai T, Ishii E. Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid carcinoma of the endometrium. Pathol Int. 2000;50:847-852.
149. Adams SF, Yamada SD, Montag A, et al. An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium. Gynecol Oncol. 2001;83:418-421.
150. Pitman MB, Young RH, Clement PB, et al. Endometrioid carcinoma of the ovary and endometrium, oxyphilic cell type: A report of nine cases. Int J Gynecol Pathol. 1994;13:290-301. (Pubitemid 24309716)
151. Silver SA, Cheung ANY, Tavassoli FA. Oncocytic metaplasia and carcinoma of the endometrium: An immunohistochemical and ultrastructural study. Int J Gynecol Pathol. 1999;18:12-19. (Pubitemid 29028840)
152. Young RH, Scully RE. Oxyphilic clear cell carcinoma of the ovary. A report of nine cases. Am J Surg Pathol. 1987;11:661-667. (Pubitemid 17148464)
153. Jones MA, Young RH, Scully RE. Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol. 1991;10:260-270.
154. Pesce C, Merino MJ, Chambers JT, et al. Endometrial carcinoma with trophoblastic differentiation. An aggressive form of uterine cancer. Cancer. 1991;68:1799-1802.
155. Kalir T, Seijo L, Deligdisch L, et al. Endometrial adenocarcinoma with choriocarcinomatous differentiation in an elderly virginal woman. Int J Gynecol Pathol. 1995;14:266-269.
156. Bradley CS, Benjamin I, Wheeler JE, et al. Endometrial adenocarcinoma with trophoblastic differentiation. Gynecol Oncol. 1998;69:74-77. (Pubitemid 28201675)
157. Molina P, Torres JV, Navarro S, et al. Uterine carcinoma with serous and choriocarcinomatous differentiation. Int J Surg Pathol. 1998;4:17-22.
158. Christopherson WM, Alberhasky RC, Connelly PJ. Glassy cell carcinoma of the endometrium. Hum Pathol. 1982;13:418-421. (Pubitemid 12092897)
159. Arends JW, Willebrand D, DeKoning Gans HJ, et al. Adenocarcinoma of the endometrium with glassy-cell features - immunohistochemical observations. Histopathology. 1984;8:873-879. (Pubitemid 15222656)
160. Dawson EC, Belinson JL, Lee K. Glassy cell carcinoma of the endometrium responsive to megestrol acetate. Gynecol Oncol. 1989;33:121-124. (Pubitemid 19106637)
161. Hachisuga T, Sugimori H, Kaku T, et al. Glassy cell carcinoma of the endometrium. Gynecol Oncol. 1990;36:134-138. (Pubitemid 20038018)
162. Mhawech P, Dellas A, Terracciano LM. Glassy cell carcinoma of the endometrium. A case report and review of the literature. Arch Pathol Lab Med. 2001;125:816-819. (Pubitemid 32520531)
163. Abeler VM, Kjorstad KE, Nesland JM. Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases. Cancer. 1991;68:98-105.
164. Wilson TO, Poddratz KC, Gaffey TA, et al. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol. 1990;162:418-426. (Pubitemid 20068510)
165. Huntsman DG, Clement PB, Gilks CG, et al. Small cell carcinoma of the endometrium: A clinicopathologic analysis of sixteen cases. Am J Surg Pathol. 1994;18:376-390.
166. van Hoeven KH, Hudock JA, Woodruff JM, et al. Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol. 1995;14:21-29.
167. Chadud F, Young RH, Remulla JF, et al. Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers. Review of a process particularly associated with gynaecologic cancers. Am J Surg Pathol. 2001;25:212-218. (Pubitemid 32167503)
168. Sekiguchi I, Suzuki M, Sato I, et al. Rare case of small-cell carcinoma arising from the endometrium with paraneoplastic retinopathy. Gynecol Oncol. 1998;71:454-457. (Pubitemid 29022337)
169. Manivel C, Wick MR, Sibley RK. Neureoendocrine differentiation in müllerian neoplasms, An immunohistochemical study of a "pure" endometrial small-cell carcinoma and a mixed müllerian tumor containing small-cell carcinoma. Am J Clin Pathol. 1986;86:438-443. (Pubitemid 16006867)
170. McLaren BK, Constantinescu M, Daley W, et al. Small cell carcinoma component in malignant mullerian mixed tumors of the uterus. Abstract. Mod Pathol. 2004;17:206A.
171. Harris NL, Scully RE. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina: A clinicopathologic analysis of 27 cases. Cancer. 1984;53:2530-2545. (Pubitemid 14102498)
172. Shih I-M, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20:31-47. (Pubitemid 32041756)
173. Daya D, Lukka H, Clement PB. Primitive neuroectodermal tumors of the uterus: a report of four cases. Hum Pathol. 1992;23:1120-1129.
174. Banks ER, Mills SE, Frierson HF Jr. Uterine intravascular menstrual endometrium simulating malignancy. Am J Surg Pathol. 1991;15:407-412.
175. Young RH, Harris NL, Scully RE. Lymphoma-like lesions of the lower female genital tract: A report of 16 cases. Int J Gynecol Pathol. 1985;4:289-299. (Pubitemid 16175328)
176. Kim K-R, Lee YH, Ro JY. Nodular histiocytic hyperplasia of the endometrium. Int J Gynecol Pathol. 2002;21:141-146. (Pubitemid 34260634)
177. Kawai K, Fukuda K, Tsuchiyama H. Malacoplakia of the endometrium: An unusual case studied by electron microscopy and a review of the literature. Acta Pathol Jpn. 1988;38:531-540.
178. Young RH, Kurman RJ, Scully RE. Placental site nodules and plaques: A clinicopathologic study of 20 cases. Am J Surg Pathol. 1990;14:1001-1009. (Pubitemid 20360706)
179. Ordi J, Nogales FF, Palacin A, et al. Mesonephric adenocarcinoma of the uterine corpus. CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol. 2001;25:1540-1545. (Pubitemid 33096970)
180. McCluggage WG, Oliva E, Herrington CS, et al. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology. 2003;43:144-150. (Pubitemid 36963158)
181. Kumar NB, Hart WR. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer. 1982;50:2163-2169. (Pubitemid 13203625)
182. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer. 1984;53:1978-1984. (Pubitemid 14127658)
183. Lemoine NR, Hall PA. Epithelial tumors metastatic to the uterine cervix. A study of 63 cases and review of the literature. Cancer. 1986;57:2002-2005. (Pubitemid 16113777)
184. Young RH, Scully RE. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix. A clinicopathological analysis of 16 cases. Int J Gynecol Pathol. 1988;7:99-111.
185. Yazigi R, Sandstad J, Munoz AK. Breast cancer metastasizing to the uterine cervix. Cancer. 1988;61:2558-2560.
186. Imachi M, Tsukamoto N, Amagase H, et al. Metastatic adenocarcinoma to the uterine cervix from gastric cancer. A clinicopathologic analysis of 16 cases. Cancer. 1993;71:3472-3477. (Pubitemid 23152652)
187. Moore WF, Bentley RC, Kim K-Y, et al. Goblet-cell mucinous epithelium lining the endometrium and endocervix: Evidence of metastases from an appendiceal primary tumor through the use of cytokeratin 7 and 20 immunostains. Int J Gynecol Pathol. 1998;17:363-367. (Pubitemid 28447166)